Hanmi Reports 2021 Fourth Quarter and Full Year Results

Written by Customer Service on January 25, 2022. Posted in Public Companies.

Reports strong earnings, record loan production, and significant improvements in asset quality LOS ANGELES, Jan. 25, 2022 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today reported financial results for the 2021 fourth quarter and full year. Net income for the fourth quarter of 2021 was $33.3 million, or $1.09 per diluted share, compared with $26.6 million, or $0.86 per diluted share for the third quarter of 2021. Net income for the fourth quarter included a recovery of credit loss expense of $16.0 million reflecting a $9.1 million recovery from a loan charge-off in the previous year. In addition, income tax expense for the fourth quarter included a $2.7 million benefit from a decrease in the valuation allowance for deferred tax assets. Return on average...

Freddie Mac Issues Monthly Volume Summary for December 2021

Written by Customer Service on January 25, 2022. Posted in Public Companies.

MCLEAN, Va., Jan. 25, 2022 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today posted to its website its Monthly Volume Summary for December 2021, which provides information on Freddie Mac’s mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities, and other investments. Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders, and taxpayers. Learn more at FreddieMac.com, Twitter @FreddieMac, and Freddie Mac’s blog FreddieMac.com/blog. MEDIA CONTACT: Fred Solomon703-903-3861Frederick_Solomon@freddiemac.com INVESTOR...

Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145

Written by Customer Service on January 25, 2022. Posted in Public Companies.

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the appointment of Shannon Campbell as Executive Vice President & Chief Commercial Officer. Ms. Campbell is an accomplished healthcare leader with demonstrated success leading commercial businesses across a range of specialty markets, including oncology. “Shannon will be instrumental in advancing Merus’ mission to become a commercial-stage company, further advancing the strategy for our lead clinical program, zenocutuzumab for neuregulin 1 fusion cancer and developing our commercial approach for our pipeline of innovative multispecific antibody...

BioLife Sciences Inc. (OTC Markets: BLFE) Signs LOI with Health Box LLC Towards the 100% Acquisition of the Arizona, USA Based Entity Specializing in Advanced Orthomolecular Medicine and Natural Health Products Development and Research

Written by Customer Service on January 25, 2022. Posted in Public Companies.

Toronto, Ontario, Canada, Jan. 25, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioLife Sciences (OTCPK : BLFE) is pleased to announce that it has entered into exclusive negotiations with Health Box LLC, an Arizona-based company which provides a diverse mix of advanced orthomolecular and natural health products founded in — extensive research focused on medicinal botanicals, micronutrients, dietary supplements, proprietary herbal blends, and apothecary style subscription services. With this contemplated acquisition, BioLife Sciences would be provided with a synergistic opportunity to expand its current healthcare product offerings into a brand-new product line of advanced orthomolecular and natural health products & solutions with a focus on (but not limited to): gastrointestinal health, endocrine health, cardiovascular...

Malibu Boats, Inc. Announces Earnings Release Date and Conference Call Information for Second Quarter Fiscal 2022 Financial Results

Written by Customer Service on January 25, 2022. Posted in Public Companies.

LOUDON, Tenn., Jan. 25, 2022 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU) announced today that it will release its second quarter fiscal 2022 financial results on Tuesday, February 8, 2022, before the market opens. Following the release, the company’s management will host a conference call to discuss the results at 8:30 a.m. Eastern Time on the same day. The call will be hosted by Malibu’s Chief Executive Officer, Jack Springer, and Chief Financial Officer, Wayne Wilson. Investors and analysts are invited to listen to the conference call by dialing (855) 433-0928 or (484) 756-4263 and using Conference ID #2119247. Alternatively, interested parties can listen to a live webcast of the conference call by logging on to the Investor Relations section of the Company’s website at http://investors.malibuboats.com/. A replay of...

Renasant Corporation Announces Earnings for the Fourth Quarter of 2021

Written by Customer Service on January 25, 2022. Posted in Public Companies.

TUPELO, Miss., Jan. 25, 2022 (GLOBE NEWSWIRE) — Renasant Corporation (NASDAQ: RNST) (the “Company”) today announced earnings results for the fourth quarter of 2021. Net income for the fourth quarter of 2021 was $37.1 million, as compared to $31.5 million for the fourth quarter of 2020. Basic and diluted earnings per share (“EPS”) were $0.66 for the fourth quarter of 2021, as compared to basic and diluted EPS of $0.56 for the fourth quarter of 2020. Net income for the year ended December 31, 2021, was $175.9 million, as compared to net income of $83.7 million for the same period in 2020. Basic and diluted EPS were $3.13 and $3.12, respectively, for 2021, as compared to basic and diluted EPS of $1.49 and $1.48, respectively, for 2020. “I am proud of the Renasant team and the efforts they put forth in 2021. We generated strong loan...

FreightCar America, Inc. Announces Upcoming Shareholder Events

Written by Customer Service on January 25, 2022. Posted in Public Companies.

Company to host conference call on February 8th to provide strategic update and outlook for 2022 CHICAGO, Jan. 25, 2022 (GLOBE NEWSWIRE) — FreightCar America, Inc. (Nasdaq: RAIL) today announced several upcoming shareholder events, including: Strategic Update Call: Conference call to provide a strategic update, brief overview of 2021 successes, as well as the go forward strategy and outlook for 2022 on Tuesday, February 8, 2022 at 11:00 a.m. (Eastern Time). Fourth Quarter Earnings Call: Conference call to discuss fourth quarter and full year 2021 results will be held on Tuesday, March 22, 2022 at 11:00 a.m. (Eastern Time). Annual Meeting: The Company’s annual meeting of stockholders will be held virtually on Thursday, May 12, 2022 at 11:00 a.m. (Eastern Time). Details for the Tuesday, February 8, 2022 conference call are below...

STERIS to Host a Conference Call for Fiscal 2022 Third Quarter Financial Results on February 9, 2022

Written by Customer Service on January 25, 2022. Posted in Public Companies.

DUBLIN, IRELAND, Jan. 25, 2022 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 third quarter financial results at 10:00 a.m. ET on February 9, 2022. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter financial results will be issued after the U.S. market closes on February 8, 2022. For those unable to listen to the conference call live, a replay will be available beginning at 12:00 p.m. ET on February 9, 2022, either at www.steris-ir.com or via phone. To access the replay of the call, please use the access code 6968500 and dial 1-877-344-7529...

Roivant to Present at Upcoming Investor Conferences

Written by Customer Service on January 25, 2022. Posted in Public Companies.

BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Jan. 25, 2022 (GLOBE NEWSWIRE) — Roivant Sciences (Nasdaq: ROIV) today announced that its CEO Matt Gline will present at two upcoming conferences: B. Riley Securities Virtual Oncology Conference on Thursday, January 27, 2022 at 12:30 p.m. ET SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 1:00 p.m. ET A live webcast of each presentation will be available under “Events & Presentations” on the Investors section of the Roivant website at https://investor.roivant.com/news-events/events and an archived recording of the presentations will be available for 30 days. About Roivant SciencesRoivant’s mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity. Roivant develops transformative medicines...

Checkpoint Therapeutics to Participate in the B. Riley Securities’ Virtual Oncology Conference

Written by Customer Service on January 25, 2022. Posted in Public Companies.

WALTHAM, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in a fireside chat hosted by Justin Walsh, Equity Research Analyst (Biotechnology), at the B. Riley Securities’ Virtual Oncology Conference, taking place on Thursday, January 27, 2022, at 11:00 a.m. EST. Checkpoint management will also participate in one-on-one meetings during the conference. A live webcast of the fireside chat will be available on the IR Calendar page under News & Events, located within the Investors section of Checkpoint’s website, https://ir.checkpointtx.com/event-calendar/default.aspx, for approximately 30 days following the meeting. About Checkpoint...

Day: January 25, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice